Discover 1,670 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,670
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
for
Metastatic Nasopharyngeal Carcinoma,
Location: New Brunswick NJ, Basking Ridge NJ, Middletown NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06029270
Phase 2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: New Brunswick NJ, Somerville NJ, Basking Ridge NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase 2, Phase 3, Recruiting
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
for
Nonmuscle-invasive Bladder Cancer
Location: New Brunswick NJ, Pittsburgh PA, Middleburg Heights OH,
Sponsor: ImmVira Pharma Co. Ltd
Sex: All
Age: 18+
Code: NCT06971614
Phase 2, Recruiting
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for
Endometrial Adenocarcinoma
Location: New Brunswick NJ, New York NY, Hackensack NJ,
Sponsor: Acrivon Therapeutics
Sex: Female
Age: 18+
Code: NCT05548296
Phase 2, Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: New Brunswick NJ, Livingston NJ, Toms River NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04628767
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase 3, Recruiting
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
for
Locoregional Recurrence,
Location: New Brunswick NJ, New York NY, Hershey PA,
Sponsor: Oana Danciu
Sex: All
Age: 18+
Code: NCT05467891
Phase 2, Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: New Brunswick NJ, New Haven CT, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase 1, Phase 2, Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Location: New Brunswick NJ, Somerville NJ, Basking Ridge NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04181060
Phase 3, Recruiting
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: New Brunswick NJ, Basking Ridge NJ, Middletown NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06484062
Phase 1, Recruiting
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
for
Malignant Female Reproductive System Neoplasm,
Location: New Brunswick NJ, Willow Grove PA, Lakewood NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06126276
Phase 2, Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: New Brunswick NJ, Morristown NJ, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase 2, Recruiting
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Location: New Brunswick NJ, Boston MA, Chicago IL, Austin TX
Sponsor: Cellectis S.A.
Sex: All
Age: 18 - 70+
Code: NCT05607420
Phase 1, Phase 2, Recruiting
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Location: New Brunswick NJ, Somerville NJ, Basking Ridge NJ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06661720
Phase 3, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Brunswick NJ, Philadelphia PA, Bala-Cynwyd PA,